ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) went up by 6.48% from its latest closing price compared to the recent 1-year high of $1.57. The company’s stock price has collected 26.87% of gains in the last five trading sessions.
Is It Worth Investing in ASLAN Pharmaceuticals Limited (NASDAQ :ASLN) Right Now?
Plus, the 36-month beta value for ASLN is at 1.47. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for ASLAN Pharmaceuticals Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
ASLN currently public float of 69.71M and currently shorts hold a 2.84% ratio of that float. Today, the average trading volume of ASLN was 204.28K shares.
ASLN’s Market Performance
ASLN stocks went up by 26.87% for the week, with a monthly jump of 26.87% and a quarterly performance of -33.51%, while its annual performance rate touched -59.44%. The volatility ratio for the week stands at 6.69% while the volatility levels for the past 30 days are set at 7.64% for ASLAN Pharmaceuticals Limited. The simple moving average for the period of the last 20 days is 31.74% for ASLN stocks with a simple moving average of -5.11% for the last 200 days.
Analysts’ Opinion of ASLN
Many brokerage firms have already submitted their reports for ASLN stocks, with Jefferies repeating the rating for ASLN by listing it as a “Buy.” The predicted price for ASLN in the upcoming period, according to Jefferies is $8 based on the research report published on July 09th of the previous year 2021.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see ASLN reach a price target of $8.50, previously predicting the price at $12. The rating they have provided for ASLN stocks is “Buy” according to the report published on January 14th, 2019.
ASLN Trading at 12.19% from the 50-Day Moving Average
After a stumble in the market that brought ASLN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.02% of loss for the given period.
Volatility was left at 7.64%, however, over the last 30 days, the volatility rate increased by 6.69%, as shares surge +34.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.73% lower at present.
During the last 5 trading sessions, ASLN rose by +26.87%, which changed the moving average for the period of 200-days by -39.89% in comparison to the 20-day moving average, which settled at $0.4604. In addition, ASLAN Pharmaceuticals Limited saw -46.76% in overturn over a single year, with a tendency to cut further losses.